Late results of mesocaval interposition shunting for bleeding oesophageal varices

✍ Scribed by Dr. O. T. Terpstra; B. Ausema; H. A. Bruining; J. S. Laméris; C. B. Reuvers; S. W. Schalm; H. van Urk; J. H. P. Wilson

• Publisher: John Wiley and Sons
• Year: 1987
• Tongue: English
• Weight: 477 KB
• Volume: 74
• Category: Article
• ISSN: 0007-1323
• DOI: 10.1002/bjs.1800740911

✦ Synopsis

Abstract
Survival, encephalopathy and shunt patency were studied in 64 consecutive patients who underwent mesocaval shunting with a wide-calibre Dacron® prosthesis. Half of the patients were operated as emergency cases. Operative blood loss in patients who had emergency procedures was significantly higher than during elective operations. Overall, 30-day mortality was 27 per cent. Survival was 61 per cent after 1 year and 39 per cent after 5 years. Serious encephalopathy requiring hospital admission occurred in 5 patients (11 per cent of patients surviving more than 1 month). Shunt patency was assessed by scintisplenoportography and ultrasonography. Cumulative shunt occlusion rate was 16 per cent after 1 year, 33 per cent after 5 years and 52 per cent after 8 years of follow-up. Out of 17 patients with an occluded shunt, 9 had persistent or recurrent bleeding, while 3 patients had recurrent bleeding despite a patent shunt. We conclude that the mesocaval Dacron interposition shunt should not be recommended as the procedure of first choice for portosystemic shunting.